Christopher Ogden Cytom X Therapeutics, Inc. (CTMX) insider trading activity

CTMX Quotes by TradingView

Christopher Ogden is Chief Financial Officer of CytomX Therapeutics, Inc.. Currently has a direct ownership of 108,077 shares of CTMX, which is worth approximately $114,561. The most recent transaction as insider was on Aug 20, 2024, when has been sold 1,984 shares (Common Stock) at a price of $1.23 per share, resulting in proceeds of $2,440. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 108K
0% 3M change
113.39% 12M change
Total Value Held $114,561

Christopher Ogden Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 20 2024
SELL
Open market or private sale
$2,440 $1.23 p/Share
1,984 Reduced 1.8%
108,077 Common Stock
Aug 20 2024
BUY
Exercise of conversion of derivative security
-
6,875 Added 5.88%
110,061 Common Stock
Jun 12 2024
BUY
Grant, award, or other acquisition
-
17,500 Added 14.5%
103,186 Common Stock
Mar 19 2024
SELL
Open market or private sale
$6,209 $2.09 p/Share
2,971 Reduced 3.35%
85,686 Common Stock
Jan 18 2024
BUY
Grant, award, or other acquisition
-
40,000 Added 31.09%
88,657 Common Stock
Dec 20 2023
SELL
Open market or private sale
$2,746 $1.38 p/Share
1,990 Reduced 3.93%
48,657 Common Stock
Dec 17 2023
BUY
Exercise of conversion of derivative security
-
6,875 Added 11.95%
50,647 Common Stock
Mar 16 2023
SELL
Open market or private sale
$1,021 $1.98 p/Share
516 Reduced 1.35%
37,772 Common Stock
Feb 02 2023
BUY
Grant, award, or other acquisition
-
25,000 Added 39.5%
38,288 Common Stock
CO

Christopher Ogden

Chief Financial Officer
South San Francisco, CA

Track Institutional and Insider Activities on CTMX

Follow CytomX Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTMX shares.

Notify only if

Insider Trading

Get notified when an Cytom X Therapeutics, Inc. insider buys or sells CTMX shares.

Notify only if

News

Receive news related to CytomX Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CTMX